BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  Syndax to Present at the SITC 32nd Annual Scientific Meeting

  Syndax today announced five presentations at the upcoming SITC 32nd Annual Meeting being held November 8-12, 2017 in National Harbor, Maryland.

  November 8, 2017

   · 

  5 min read
• Business

  Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update

  Clearside’s research and development expenses for the three months ended September 30, 2017 were $16.1 million, compared to $3.7 million for the third quarter of 2016.

  November 8, 2017

   · 

  9 min read
• Business

  Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13

  Management will host an investment community conference call on Monday, November 13, at 8:30am ET.

  November 8, 2017

   · 

  3 min read
• Business

  Chimerix Announces Third Quarter 2017 Financial Results

  Chimerix reported a net loss of $17.3 million, or $0.37 per basic and diluted share, for the third quarter of 2017.

  November 8, 2017

   · 

  8 min read
• Business

  Amicus Therapeutics Announces Third Quarter 2017 Financial Results and Corporate Updates

  The Company also summarized recent program updates and reiterated full-year 2017 financial guidance.

  November 8, 2017

   · 

  17 min read
• Business

  Awair Partners With Brown University to Study Effects of Environmental Exposures on Neurodevelopment in Children

  Awair today announces its partnership with Brown University’s Baby Imaging Lab to collaborate on a NIH-sponsored project called “Resonance”, a longitudinal study that focuses on understanding how a wide variety of environmental exposures affect child neurodevelopment.

  November 8, 2017

   · 

  2 min read
• Business

  Neos Therapeutics Reports Third Quarter 2017 Financial Results

  Total product revenues were $6.7 million for the three months ended September 30, 2017, compared to $1.6 million for the same period in 2016.

  November 8, 2017

   · 

  11 min read
• Business

  Leading UK Drug Developer RxCelerate Opens First U.S. Base in Boston

  RxCelerate announced today it has hired Laura Hamilton as Executive VP, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston.

  November 8, 2017

   · 

  5 min read
• Business

  Paratek Pharmaceuticals Reports Third Quarter 2017 Financial Results, Remains on Track to Complete NDA Submissions in First Quarter of 2018

  Paratek reported a net loss of $21.3 million, or ($0.77) per share, for the quarter ended September 30, 2017 compared to a net loss of $23.6 million, or ($1.04) per share, for the same period in 2016.

  November 8, 2017

   · 

  8 min read
• Biotech Beach

  Vical Incorporated Announces Pricing of $25M Underwritten Public Offering of Common Stock

  H.C. Wainwright & Co., LLC is acting as the sole book-running manager for the offering.

  November 8, 2017

   · 

  2 min read